AI has enormous potential to improve the quality of health care, enable early diagnosis of diseases, and reduce costs. But if implemented incautiously, AI can exacerbate health disparities, endanger privacy rights, and perpetuate bias. STAT, with support from the Commonwealth Fund, is exploring these possibilities and pitfalls, illuminating best practices while identifying regulatory gaps.
Coverage supported by:
A STAT investigation has found that the FDA did not require developers of many AI tools to publicly disclose data used to test the systems.
Read The Story
